A novel ternary ligand system useful for preparation of cationic 99mTc-diazenido complexes and 99mTc-labeling of small biomolecules

Bioconjugate Chemistry

Volumn 17, Issue 2, 2006, Pages 473-484

  Kim, Young Seung ^a   He, Zhengjie ^a   Hsieh, Wen Yuan ^a   Liu, Shuang ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; COUPLING AGENTS; CROWN ETHERS; EFFICIENCY; LIGANDS; REACTION INTERMEDIATES; SYNTHESIS (CHEMICAL);

BISPHOSPHINE; CATIONICS; CROWN-ETHERS; DIAMINOPROPANE; DITHIOCARBAMATES; HEART IMAGING; LABELING EFFICIENCIES; LABELINGS; LIGAND SYSTEM; PHENYLHYDRAZINE;

CHLORINE COMPOUNDS;

1,2 DIAMINOPROPANE N,N,N',N' TETRAACETIC ACID; 4 HYDRAZINOBENZOIC ACID; 6 HYDRAZINONICOTINIC ACID; ACETIC ACID DERIVATIVE; CATION; CROWN ETHER DERIVATIVE; DITHIOCARBAMIC ACID DERIVATIVE; N,N BIS[2 [BIS(3 ETHOXYPROPYL)PHOSPHINO]ETHYL]ETHOXYETHYLAMINE; PHENYLHYDRAZINE; PHOSPHINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SODIUM N (DITHIOCARBAMATO) 2 AMINOMETHYL 15 CROWN 5; STANNOUS CHLORIDE; TECHNETIUM 99M; TRISODIUM TRIPHENYLPHOSPHINE 3,3',3'' TRISULFONATE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; HEART; HIGH TEMPERATURE; ISOTOPE LABELING; LIPOPHILICITY; REACTION ANALYSIS;

EID: 33645524771     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0502715     Document Type: Article

References (79)

1. Abrams, M. J., Juweid, M., tenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss, H. W., and Fischman, A. J. (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
2. 99mTc-protein conjugates. Bioconjugate Chem. 2, 333-336.
3. Ultee, M. E., Bridger, G. J., Abrams, M. J., Longley, C. B., Burton, C. A., Larsen, S. K., Henson, G. W., Padmanabhan, S., Gaul, F. E., and Schwartz, D. A. (1997) Tumor imaging with technetium-99m-labeled hydrazinonicotinamide- Fab′ conjugates. J. Nucl. Med. 38, 133-138.
4. 99mTc-labeling of Fab′ monoclonal antibody fragments. Bioconjugate Chem. 7, 255-264.
5. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H., and Fischman, A. J. (1993) Technetium-99m labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1964-1974.
6. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 22, 25-30.
7. 111In IgG. Nucl. Med. Biol. 22, 643-648.
8. 4N)} core. Inorg. Chim. Acta 309, 123-136.
9. 99mTc-labeled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution. Nucl. Med. Biol. 26, 389-396.
10. 3]Octreotide. Bioconjugate Chem. 10, 431-438.
11. Decristoforo, C. and Mather, S. J. (1999) Technetium-99m somatostatin analogues: effect of labeling methods and peptide sequence. Eur. J. Nucl. Med. 26, 869-876.
12. 111In-Octreotide. J. Nucl. Med. 41, 1114-1119.
13. 1-octreotide. Eur. J. Nucl. Med. 27, 628-637.
14. 111In-labeled octreotide derivatives. Eur. J. Nucl. Med. 27, 1318-1325.
15. 3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled antisense DNA. Eur. J. Nucl. Med. 27, 1700-1707.
16. Hnatowich, D. J., Winnard, P. Jr., Virzi, F., Fogarasi, M., Santo, T., Smith, C. L., Cantor, C. R., and Rusckowski, M. (1995) Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36, 2306-2314.
17. 99mTc-HYNIC- folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40, 1563-1569.
18. 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides. Nucl. Med. Biol. 28, 155-164.
19. 99mTc-labeled peptides with low in vivo protein binding. Nucl. Med. Biol. 28, 215-224.
20. 99mTc-labeling kinetics of four thiol-containing chelators and 2-hydrazinopyridine: factors influencing their radiolabeling efficiency. Appl. Radiat. Isot. 48, 1103-1111.
21. 99mTc-labeling of hydrazinonicotinamide modified highly potent small molecules: Problems and solutions. Transition Metal them. 22, 425-426.
22. 99mTc- labeling of highly potent small peptides. Bioconjugate Chem. 8, 621-636.
23. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev. 99, 2235-2268.
24. Liu, S. and Edwards, D. S. (2001) New Radiopharmaceuticals for imaging infection and inflammation. Drugs Future 26, 375-382.
25. 99mTc-labeling of small biomolecules. Topics Curr. Chem. 252, 117-153.
26. 3 directed radiopharmaceuticals for tumor imaging. Drugs Future 28, 551-564.
27. Edwards, D. S., Liu, S., Ziegler, M. C., Harris, A. R., Crocker, A. C., Heminway, S. J., Barrett, J. A., Bridger, G. J., Abrams, M. J., and Higgins, J. D. (1999) RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging. Bioconjugate Chem. 10, 884-891.
28. van der Laken, C. J., Boerman, O. C., Oyen, W. J., van de Yen, M, T. P., Edwards, D. S., Barrett, J. A., van der Meer, J. W., and Corstens, F. H. (1997) Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation. J. Nucl. Med. 38, 1310-1315.
29. van Eerd, J. E. M., Oyen, W. J. G., Harris, T. D., Rennen, H. J. J. M., Edwards, D. S., Liu, S., Ellars, C. E., Corstens, F. H. M., and Boerman, O. C. (2003) A bivalent leukotriene B4 antagonist for scintigraphic imaging of infectious foci. J. Nucl. Med. 44, 1087-1091.
30. m-labeled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits. Nucl. Med. Commun. 21, 1043-1050.
31. 4 receptor antagonist useful for imaging infection and inflammation. Bioconjugate Chem. 13, 881-886.
32. 99mTc-Labeling of a hydrazinonictotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors. Bioconjugate Chem. 12, 624-629.
33. 99mTc using aminocarboxylates as co-ligands. Bioconjugate Chem. 7, 63-71.
34. 99mTc. Bioconjugate Chem. 8, 146-154.
35. 99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjugate Chem. 10, 803-807.
36. 2 formulation for RP444: a new radiopharmaceutical for thrombus imaging. J. Pharm. Sci. 90, 114-123.
37. 99mTc-labeling hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjugate Chem. 10, 803-807.
38. Liu, S., Edwards, D. S., Harris, A. R., Heminway, S. J., and Barrett, J. A. (1999) Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: Synthesis and characterization. Inorg. Chem. 38, 1326-1335.
39. 99mTc-labeled bioconjugates. Bioconjugate Chem. 11, 113-117.
40. 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N containing heterocycles as coligands. Bioconjugate Chem. 9, 583-595.
41. 99mTc-labeling of small biomolecules. Bioconjugate Chem. 14, 720-727.
42. 99mTc-labeling of small biomolecules. Bioconjugate Chem. 15, 728-737.
43. 2O, a complex exhibiting linear hydrazido(2-) ligation and end-on hydrazido(1-) ligation. J. Chem. Soc., Chem. Commun. 6, 367.
44. 2], a complex with a hydrazido(2-) ligand with a large angular distortion. Inorg. Chem. 24, 2594-2595.
45. Archer, C. M., Dilworth, J. R., Jobanputra, P., Thompson, R. M., McPartlin, M., Povey, D. C., Smith, G. W., and Kelly, J. D. (1990) Development of new technetium cores containing technetium-nitrogen multiple bonds. Synthesis and characterization of some diazenido-, hydrazido- and imido- complexes of technetium. Polyhedron 9, 1497-1502.
46. 2O. J. Chem. Soc., Dalton Trans. 897-904.
47. 4]. J. Chem. Soc., Dalton Trans. 1251-1256.
48. 3)]. Z. Naturforsch. 46, 449-452.
49. 2)], a precursor in the synthesis of organosulfinato complexes of rhenium. Inorg. Chim. Acta 134, 191-193.
50. 2]. Polyhedron 6, 1577-1585.
51. 3). Polyhedron 7, 171-185.
52. 2]. Polyhedron 12, 513-522.
53. 6]. J. Chem. Soc., Dalton Trans. 1663-1669.
54. 2. Inorg. Chim. Acta 185, 7-15.
55. 3)]. Inorg. Chim. Acta 279, 206-209.
56. 2HyNNR)} Core and Their Relationship to Radio-labeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications. Inorg. Chem. 37, 2701-2716.
57. 4N)]. Inorg. Chim. Acta 252, 421-426.
58. 4N)]. Inorg. Chim. Acta 252, 427-430.
59. Hirsch-Kuchma, M., Nicholson, T., Davison, A., Davis, W. M., and Jones, A. G. (1997) Synthesis and characterization of rhenium-(III) and technetium(III) organohydrazide chelate complexes. Reactions of 2-hydrazinopyridine with complexes of rhenium and technetium. Inorg. Chem. 36, 3237-3241.
60. 2]. Inorg. Chim. Acta 271, 191-194.
61. Hirsch-Kuchma, M., Nicholson, T., Davison, A., and Jones, A. G. (1997) Group 7 Organohydrazide' chemistry: classification of ligand type based on crystal structural data. J. Chem. Soc., Dalton Trans. 3189-3192.
62. Hirsch-Kuchma, M., Nicholson, T., Davison, A., Davis, W. M., and Jones, A. G. (1997) The synthesis and characterization of technetium and rhenium hydrazinopyrimidine chelate complexes. J. Chem. Soc., Dalton Trans. 3185-3188.
63. 99mTcN-DBODC5. Nucl. Med. Biol., submitted.
64. 99Tc and Re; DTC = dithiocarbamate; PNP = heterodiphosphane). Eur. J. Inorg. Chem. 1902-1913.
65. Bolzati, C., Boschi, A., Duatti, A., Prakash, S., and Uccelli, L. (2000) Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands. J. Am. Chem. Soc. 122, 4510-4511.
66. 2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules. J. Am. Chem. Soc. 124, 11468-11479.
67. Cowley, A. R., Dilworth, J. R. and Dormelly, P. S. (2003) A mono-diazenide complex from perrhenate: toward a new core for rhenium radiopharmaceuticals. Inorg. Chem. 42, 929-931.
68. Jones, A. G., Abrams, M. J., Davison, A., Brodack, J. W., Toothaker, A. K., Adelstein, S. J. and Kassis, A. I. (1984) Biological studies of a new class of technetium complexes: the hexakis-(alkylisonitrile)technetium(I) cations. Int. J. Nucl. Biol 11, 225-234.
69. Carvalho, P. A., Chiu, M. L., Kronauge, J. F., Kawamura, M., Jones, A. G., Holman, B. L., and Piwnica-Worms, D. (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J. Nucl. Med. 33, 1516-1521.
70. Iskandrian, A. S., Heo, J. Y., Kong, B., Lyons, E., and Marsch, S. (1989) Use of technitium-99m Isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am. J. Cardiol. 64, 270-275.
71. Mousa, S. A., Cooney, J. M., and Williams, S. J. (1987) Flow-distribution characteristics of Tc-99m-Hexakis-2-methoxy-2-methylpropyl isonitrile in animal-models of myocardial-ischemia and perfusion (abstract). J. Am. Coll. Cardiol. 9, A137.
72. Crane, P., Laliberte, R., Heminway, S., Thoolen, M., and Orlandi, C. (1993) Effect of mitochondrial viability and metabolism on technetium-99m- sestamibi myocardial retention. Eur. J. Nucl. Med. 20, 20-25.
73. 2en = N,N′-ethylenebis[acety-lacetone iminato]). Nucl. Med. Biol. 26, 755-770; references therein.
74. + complexes containing ether analogs of DMPE. Nucl. Med. Biol. 26, 563-571.
75. - = thiolate). J. Med. Chem. 39, 1253-1261.
76. 99mTc heterocomplexes as heart imaging agents with improved biological properties. Nucl. Med. Commun. 23, 689-693.
77. 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. J. Nucl. Med. 44, 806-814.
78. 99mTc-Tetrofosmin in rats. J. Nucl. Med. 45, 2095-2101.
79. 3+ and metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds. Inorg. Chem. 44, 4766-4776.